C-Rad AB (publ) (FRA:24C)

Market Cap	80.06M -14.3%
Revenue (ttm)	40.83M -5.8%
Net Income	970.23K -81.4%
EPS	0.03 -81.4%
Shares Out	n/a
PE Ratio	82.51
Forward PE	12.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.275
Previous Close	2.330
Day's Range	2.275 - 2.275
52-Week Range	2.200 - 3.310
Beta	n/a
RSI	42.68
Earnings Date	May 6, 2026

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports pr...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2004
• Employees: 110
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 24C

Financial Performance

In 2025, C-Rad AB's revenue was 441.90 million, a decrease of -5.78% compared to the previous year's 469.00 million. Earnings were 10.50 million, a decrease of -81.40%.

Financial numbers in SEK